Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sexual Dysfunctions, Psychological 1Ovarian Neoplasms 1Obesity 1Neoplasms, Second Primary 1Metabolic Syndrome 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Healthy Adult Participants 1Dyslipidemias 1Carcinoma, Non-Small-Cell Lung 1Behavior, Addictive 1

Interventions

Tirzepatide 9Exercise 5Counseling 4semaglutide 3Resistance Training 3Methods 3Tablets 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Progestins 2Nutrition Assessment 2Metformin 2Megestrol Acetate 2Diet Therapy 2mirabegron 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1atezolizumab 1Weights and Measures 1Walk Test 1Vitamin D 1Urine Specimen Collection 1Trehalase 1Topiramate 1Therapeutics 1TIC10 compound 1Sugars 1Stents 1Spermine Synthase 1Sampling Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Bupropion × 1 year × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡